Patrick Baeuerle

Company: Cullinan Therapeutics

Job title: Chief Scientific Advisor and Chairman of Scientific Advisory Board

Seminars:

Affirming the Practical Edge of T-Cell Engagers Over CAR-Ts in Autoimmune Indications 9:30 am

Highlighting how T-cell engagers eliminate the time, complexity, and infrastructure burden of autologous CAR-T therapies, offering a plug-and-play treatment modality that’s immediately available at the bedside Unpacking the operational and clinical risks of CAR-T (e.g. ICU admissions, lymphodepletion, secondary malignancy risk) and contrasting them with the more controlled, predictable, and scalable safety profile of TCEs…Read more

day: Day One